Australia markets closed

Sera Prognostics, Inc. (SERA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6900+0.0400 (+2.42%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.6500
Open1.7300
Bid1.0000 x 900
Ask1.7200 x 1000
Day's range1.6500 - 1.7300
52-week range1.1500 - 11.4100
Volume9,317
Avg. volume62,738
Market cap52.394M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.8360
Earnings date10 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.00
  • PR Newswire

    BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS

    Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, and Banner Health today announced that Sera's PreTRM® Test will be available to Banner – University Family Care/ AHCCCS Complete Care (B – UFC/ACC) members. The PreTRM® Test is the only broadly clinically validated, commercially available blood test that provides an early, individual risk assessment for sp

  • Simply Wall St.

    Is Sera Prognostics (NASDAQ:SERA) In A Good Position To Invest In Growth?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

  • Motley Fool

    Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript

    Good afternoon and welcome to the Sera Prognostics' conference call to review the second quarter fiscal year 2022 results. At the close of the market today, Sera Prognostics released its financial results for the quarter ended June 30, 2022. Presenting for the company today will be Greg Critchfield, chairman, president, and CEO; and Jay Moyes, our CFO.